So far, all three universities have their own offers to promote start-up projects from research. These are to be bundled in the future in order to jointly support and network start-up teams from Central Germany and also start-ups from abroad. For this purpose, the establishment of an international start-up academy is planned, in which experts from the university start-up networks will pass on their knowledge of competence and strategy development to start-ups and researchers interested in start-ups in the form of online courses and workshops.
In addition, the universities want to work together to attract more international founders to the region of Central Germany. This includes the targeted recruitment and preparation of international business start-ups, but also the initiation of new international research collaborations and networking with the local start-up scene.
The group's third focus is on facilitating German startups' access to Asian markets. Start-ups are to be supported with the market launch of their own products and services, the acquisition of investors, the identification of suitable suppliers and the establishment of cooperation in the field of research and development.
The "International Startup Campus" is a joint project of the Martin Luther University Halle-Wittenberg, the Friedrich Schiller University Jena and the University of Leipzig. It is headed by the Leipzig economist Prof. Dr. Utz Dornberger.
Further information on the International Startup Campus at:
With the 2nd public ideas competition, the innovation region of central Germany is looking for innovative projects that have positive effects on structural change in the central German mining area. Until July 17th, project ideas with a model character can be submitted for funding via the "Untersuchungs Revier" program.
On May 20, 2020, the junior research group Astacinproteinases at the Fraunhofer Institute for Cell Therapy and Immunology IZI started its work. Led by Dr. Daniel Ramsbeck, the group is primarily concerned with the design and further development of meprin inhibitors and the development of inhibitors of ovastacin. The research group will be funded for almost two years by the investment bank Saxony-Anhalt with funds from the European Regional Development Fund (ERDF).